Hanan Shehata

632 total citations
27 papers, 518 citations indexed

About

Hanan Shehata is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hanan Shehata has authored 27 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Hanan Shehata's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (4 papers). Hanan Shehata is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (4 papers). Hanan Shehata collaborates with scholars based in Egypt, Australia and United Kingdom. Hanan Shehata's co-authors include Sanaa Eissa, Marwa Matboli, O. El-Ahmady, Md. Imtaiyaz Hassan, Menha Swellam, Amal Mansour, Ehab M. M. Ali, Eman K. Habib, Eman Khairy and Samar K. Kassim and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Journal of Cellular Biochemistry.

In The Last Decade

Hanan Shehata

26 papers receiving 509 citations

Peers

Hanan Shehata
Hanan Shehata
Citations per year, relative to Hanan Shehata Hanan Shehata (= 1×) peers Ping Jiang

Countries citing papers authored by Hanan Shehata

Since Specialization
Citations

This map shows the geographic impact of Hanan Shehata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanan Shehata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanan Shehata more than expected).

Fields of papers citing papers by Hanan Shehata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanan Shehata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanan Shehata. The network helps show where Hanan Shehata may publish in the future.

Co-authorship network of co-authors of Hanan Shehata

This figure shows the co-authorship network connecting the top 25 collaborators of Hanan Shehata. A scholar is included among the top collaborators of Hanan Shehata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanan Shehata. Hanan Shehata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassan, Mohamed K., et al.. (2024). miRNAs: possible regulators of toll like receptors and inflammatory tumor microenvironment in colorectal cancer. BMC Cancer. 24(1). 824–824. 2 indexed citations
2.
Ahmed, Hend M., et al.. (2022). Ameliorative effect of Lactobacillus rhamnosus GG on acetaminophen-induced hepatotoxicity via PKC/Nrf2/PGC-1α pathway. Journal of Genetic Engineering and Biotechnology. 20(1). 142–142. 12 indexed citations
3.
Ghattas, Maivel H., et al.. (2021). Silencing the epitranscriptomic writer METTL3 in Hepatocellular carcinoma cells: A prospective therapeutic approach. Gene Reports. 25. 101359–101359. 1 indexed citations
4.
Matboli, Marwa, et al.. (2020). Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literature. Expert Review of Precision Medicine and Drug Development. 5(6). 455–468. 5 indexed citations
5.
Matboli, Marwa, et al.. (2017). Clinical Significance of MIRNA-Autophagy Transcript Expression in Patients With Hepatocellular Carcinoma. Biomarkers in Medicine. 11(8). 641–656. 2 indexed citations
6.
Eissa, Sanaa, et al.. (2015). MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer. Tumor Biology. 36(6). 4487–4494. 35 indexed citations
7.
Mansour, Amal, et al.. (2015). A Novel Approach to Acute Lymphoblastic Leukemia in Adults: Association Analysis of Polymorphisms in Vascular Endothelial Growth Factor (VEGF) Gene and Clinical Outcome. International Journal of Cancer Research. 11(2). 93–103. 2 indexed citations
8.
Eissa, Sanaa, Marwa Matboli, & Hanan Shehata. (2014). Breast tissue–based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer. Translational research. 165(3). 417–427. 29 indexed citations
9.
Shehata, Hanan, et al.. (2013). HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker. Medical Oncology. 30(1). 460–460. 18 indexed citations
10.
Shehata, Hanan, et al.. (2013). HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.. SHILAP Revista de lepidopterología. 34(6). 407–17. 13 indexed citations
11.
Shehata, Hanan, et al.. (2013). Effect of Pre-Discharge Instructions on Prevention of Headache and Its Associated Symptoms among Patients Undergoing Diagnostic Lumber Puncture.
12.
Shehata, Hanan, et al.. (2013). HER1R497K andHER2I655V Polymorphisms Are Linked to Development of Breast Cancer. Disease Markers. 34(6). 407–417. 10 indexed citations
13.
Shehata, Hanan, et al.. (2012). Histone Deacetylases Enzyme, Copper, and IL-8 Levels in Patients With Alzheimer’s Disease. American Journal of Alzheimer s Disease & Other Dementias®. 28(1). 54–61. 72 indexed citations
14.
Eissa, Sanaa, et al.. (2012). Urinary retinoic acid receptor-β2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer. Clinical Biochemistry. 45(6). 402–407. 18 indexed citations
15.
Eissa, Sanaa, et al.. (2012). Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer. Medical Oncology. 29(5). 3345–3351. 17 indexed citations
16.
Shehata, Hanan, et al.. (2011). Prognostic significance of survivin and tumor necrosis factor-alpha in adult acute lymphoblastic leukemia. Clinical Biochemistry. 45(1-2). 112–116. 22 indexed citations
17.
Eissa, Sanaa, Menha Swellam, Samar K. Kassim, et al.. (2011). Aberrant Methylation ofRARβ2andAPCGenes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Nonbilharzial Bladder Cancer. Cancer Epidemiology Biomarkers & Prevention. 20(8). 1657–1664. 38 indexed citations
18.
Hassan, Md. Imtaiyaz, et al.. (2010). Antineoplastic Effects of Bee Honey and Nigella sativa on Hepatocellular Carcinoma Cells. Integrative Cancer Therapies. 11(4). 354–363. 45 indexed citations
19.
Ali, Ehab M. M., et al.. (2009). Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus. Clinical Biochemistry. 42(13-14). 1394–1400. 34 indexed citations
20.
Shehata, Hanan, et al.. (2009). Detection of survivin protein in aqueous humor and serum of retinoblastoma patients and its clinical significance. Clinical Biochemistry. 43(4-5). 362–366. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026